Press and Public Relations

Press and Public Relations

Press Officer and Head of Press and Public Relations (in ch.)

Dr. Sibylle Kohlstädt

Im Neuenheimer Feld 280
69120 Heidelberg

Phone: +49 6221 422854
Fax: +49 6221 422968

E-Mail: s.kohlstaedt@dkfz.de
or presse@dkfz.de

Recent Press Releases

No. 27c | 18. May 2017 | by Koh

Stop signal for dangerous immune responses

Molecular model of Annexin
© Lijealso, Wikimedia Commons

Scientists from the German Cancer Research Center (DKFZ) have copied a trick that dying cells use to prevent an undesired immune response. They now plan to develop this biological principle into a therapy method that specifically blocks allergic reactions or autoimmune responses without suppressing the whole immune system. The Federal Ministry of Education and Research (BMBF) contributes funds of €1.3 million to this project.

learn more

No. 27 | 16. May 2017 | by Rei/Koh

Defective intercellular connections cause hydrocephalus

Scanning electron microscopy image of impaired ependymal cell layer within ...
© Anja Feldner, Manfred Ruppel, DKFZ

A defective gene leads to changes in the cellular layer between cerebrospinal fluid and brain nervous tissue, thus causing a buildup of fluid in the brain. This link, which scientists from the German Cancer Research Center in Heidelberg have now discovered, is the first known mechanism underlying genetic hydrocephalus.

learn more

No. 26 | 10. May 2017 | by AM

Diagnosis of children’s brain tumors – not every tumor marker is helpful

Medulloblastomas (yellow circle) are one of the most common malignant tumor...
© Marc Remke / Universitätsklinikum Düsseldorf

With the help of molecular tumor diagnostics, cancer medicine is able to filter out individual cancer properties, in order to recommend the most promising and potentially successful treatment options to patients. However, just how reliable such prognoses are also depends on the spatial distribution of the tumor markers inside a tumor. A current study by scientists at the German Cancer Consortium (DKTK) at the University Hospital Düsseldorf shows that for children's brain tumors a single tissue sample suffices in order to make reliable prognoses using gene activity patterns. Comparatively, genetic markers are usually too unevenly distributed in the tumor, thus making several biopsies necessary, the study shows. The DKTK combines the German Cancer Research Center in Heidelberg as the core center together with various university locations across Germany with a specific oncological focus.

learn more

Audio (in German only)

more

einblick (in German only)

Publications

Videos (in German only)

RSS-Feed

Subscribe to our RSS-Feed.

to top